About china shineway - CSWYF
China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. Its products include Shen Mai injection, Qing Kai Ling injection, and Wu Fu Xin Nao Qing soft capsule. The company was founded by Zhen Jiang Li and Yun Xia Xin on August 14, 2002 and is headquartered in Shijiazhuang, China.
CSWYF At a Glance
China Shineway Pharmaceutical Group Ltd.
Luan Cheng
Shijiazhuang, Hebei 051430
| Phone | 86-311-88030066 | Revenue | 637.48M | |
| Industry | Pharmaceuticals: Other | Net Income | 136.84M | |
| Sector | Health Technology | 2023 Sales Growth | 8.655% | |
| Fiscal Year-end | 12 / 2024 | Employees | 3,436 | |
| View SEC Filings |
CSWYF Valuation
| P/E Current | 6.028 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 5.141 |
| Price to Sales Ratio | 1.103 |
| Price to Book Ratio | 0.709 |
| Price to Cash Flow Ratio | 5.013 |
| Enterprise Value to EBITDA | -0.601 |
| Enterprise Value to Sales | -0.137 |
| Total Debt to Enterprise Value | -0.486 |
CSWYF Efficiency
| Revenue/Employee | 185,528.616 |
| Income Per Employee | 39,825.16 |
| Receivables Turnover | 3.414 |
| Total Asset Turnover | 0.503 |
CSWYF Liquidity
| Current Ratio | 3.351 |
| Quick Ratio | 2.982 |
| Cash Ratio | 2.428 |
CSWYF Profitability
| Gross Margin | 75.149 |
| Operating Margin | 21.479 |
| Pretax Margin | 27.46 |
| Net Margin | 21.466 |
| Return on Assets | 10.80 |
| Return on Equity | 14.329 |
| Return on Total Capital | 13.229 |
| Return on Invested Capital | 14.327 |
CSWYF Capital Structure
| Total Debt to Total Equity | 4.283 |
| Total Debt to Total Capital | 4.107 |
| Total Debt to Total Assets | 3.147 |
| Long-Term Debt to Equity | 0.005 |
| Long-Term Debt to Total Capital | 0.005 |